Chile vs Myanmar: Treatment success rate: XDR-TB cases
Chile
75
in 2022
Myanmar
79
in 2022
Chile rank
29th
Myanmar rank
27th
Treatment success rate: XDR-TB cases over time
- Chile
- Myanmar
How they compare
Myanmar currently reports 79 against 75 in Chile, a difference of 4.
That makes Myanmar's figure about 1.1 times Chile's.
Across all 5 years both countries report, Myanmar has been ahead every year.
Chile ranks 29th and Myanmar ranks 27th of 82 countries.
Myanmar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 40 | 72.5 | 32.5 | Myanmar |
| 2020s | 85 | 88 | 3 | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Chile or Myanmar?
- Myanmar, at 79 against 75 in Chile as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Chile and Myanmar?
- 4, with Myanmar ahead.
- How many years of comparable data are there for Chile and Myanmar?
- 5 years are reported by both, from 2018 to 2022.
- How do Chile and Myanmar rank globally for treatment success rate: xdr-tb cases?
- Chile ranks 29th and Myanmar ranks 27th of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.